Home › NDC Lookup › RxCUI directory › RxCUI 2197884

Pitolisant 4.45 MG Oral Tablet — RxCUI 2197884

RxNorm drug concept · Semantic clinical drug
RxCUI 2197884 Semantic clinical drug · SCD ● Current RxNorm concept 2 FDA products 2 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI2197884
Official namePitolisant 4.45 MG Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known aspitolisant 4.45 MG (as pitolisant HCl 5 MG) Oral Tablet
FDA products mapped2
Package NDCs mapped2
Reported Medicaid activity (SDUD)10,461 prescriptions · 41 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Pitolisant: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • It treats excessive daytime sleepiness or cataplexy (sudden muscle weakness) in people with narcolepsy. It is approved for adults and children 6 and older.
  • Take it by mouth once a day in the morning when you wake up. Your dose starts low and is raised over a few weeks. Food does not meaningfully affect it, so you can take it either wa...
  • Headache, trouble sleeping, nausea and anxiety are the most common. Call your doctor if you have a racing or irregular heartbeat, fainting, seizures, hallucinations, or mood change...
  • Tell me about everything you take. Some drugs raise or lower Wakix levels, and drugs that affect heart rhythm should be avoided. Certain allergy medicines that enter the brain may...
📖 Read our full Pitolisant guide →

🕸️ Concept Web — How Pitolisant 4.45 MG Oral Tablet Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Pitolisant 4.45 MG Oral Tablet RxCUI 2197884

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Pitolisant 2197878
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Wakix 2197885
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Pitolisant Oral Tablet 2197883
    • Pitolisant Oral Product 2197881
    • Pitolisant Pill 2197882
    • Pitolisant Oral Tablet [Wakix] 2197887
    • Wakix Oral Product 2197888
    • Wakix Pill 2197889
    • Oral Tablet 317541
    • Oral Product 1151131
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Pitolisant 4.45 MG SCDC · 2197880
  • Pitolisant Oral Tablet SCDF · 2197883
  • Pitolisant Oral Product SCDG · 2197881
  • Pitolisant Pill SCDG · 2197882

Brand-Name Concepts

  • Pitolisant 4.45 MG Oral Tablet [Wakix] SBD · 2197890
  • Pitolisant 4.45 MG [Wakix] SBDC · 2197886
  • Pitolisant Oral Tablet [Wakix] SBDF · 2197887
  • Wakix Oral Product SBDG · 2197888
  • Wakix Pill SBDG · 2197889
  • Wakix BN · 2197885

📦 FDA Products & Package NDCs

2 products · 2 package NDCs
2 package NDCs map to RxCUI 2197884 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
72028-0045-03 1 BOTTLE, PLASTIC in 1 CARTON (72028-045-03) / 30 TABLET, F... Wakix Harmony Biosciences, LLC 2019-08-14
72028-0178-03 1 BOTTLE, PLASTIC in 1 CARTON (72028-178-03) / 30 TABLET, F... Wakix Harmony Biosciences, LLC 2019-08-14
Observed labelers: Harmony Biosciences, LLC (2) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.